Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score‐adjusted untreated patients

Norii, Tatsuya MD; Crandall, Cameron MD; Terasaka, Yusuke MD

Journal of Trauma and Acute Care Surgery: April 2015 - Volume 78 - Issue 4 - p 721–728
doi: 10.1097/TA.0000000000000578
Original Articles
Editor's Choice

BACKGROUND Despite a growing call for use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for critically uncontrolled hemorrhagic shock, there is limited evidence of treatment efficacy. We compared the mortality between patients who received a REBOA with those who did not, adjusting for the likelihood of treatment and injury severity, to measure efficacy.

METHODS We analyzed observational prospective data from the Japan Trauma Data Bank (2004–2011) to compare the mortality between adult patients who received a REBOA with those who did not. To adjust for potential treatment bias, we calculated the likelihood of REBOA treatment via a propensity score (PS) using available pretreatment variables (vital signs, age, sex, as well as anatomic and physiologic injury severity) and matched treated patients to up to five similar PS untreated patients. We compared survival to discharge between treated and untreated groups using conditional logistic regression and Cox proportional hazards regression.

RESULTS Of 45,153 patients who met inclusion, 452 patients (1.0%) received REBOA placement. These patients were seriously injured (median Injury Severity Score [ISS], 35) and had high mortality (76%). Patients who did not receive a REBOA had significantly lower injury severity (median ISS, 13; p < 0.0001) and lower mortality (16%). After matching REBOA patients with controls with similar PSs for treatment, the crude conditional odds ratio of survival by REBOA treatment was 0.30 (95% confidence interval, 0.23–0.40).

CONCLUSION REBOA treatment is associated with higher mortality compared with similarly ill trauma patients who did not receive a REBOA. The higher observed mortality among REBOA-treated patients may signal “last ditch” efforts for severity not otherwise identified in the trauma registry.

LEVEL OF EVIDENCE Epidemiologic study, level III; therapeutic study, level IV.

From the Department of Emergency Medicine, University of New Mexico (T.N., C.C.), Albuquerque, New Mexico and Department of Emergency Medicine, Kenwakai Otemachi Hospital (Y.T.), Kitakyushu, Japan.

Submitted: August 14, 2014, Revised: December 1, 2014, Accepted: December 3, 2014, Published online: March 4, 2015.

This study was presented at the 2013 Scientific Assembly of American College of Emergency Physicians (ACEP), Seattle, October 15, 2013.

Address for reprints: Tatsuya Norii, MD, Department of Emergency Medicine, MSC11 6025 Lomas Blvd NE, Albuquerque, NM 87131–0001; email:

© 2015 Lippincott Williams & Wilkins, Inc.